TGF-β: the connecting link between nephropathy and fibrosis

Area of Science:

• Nephrology
• Cell Biology
• Molecular Medicine

Background:

• Renal fibrosis, characterized by excessive extracellular matrix (ECM) accumulation, is a common pathway to end-stage renal failure in conditions like diabetic and membranous nephropathy.
• Chronic inflammation and molecular signaling contribute to ECM buildup, often involving epithelial to mesenchymal transition (EMT).

Purpose of the Study:

• To review recent findings on the mechanisms and role of transforming growth factor-beta (TGF-β) in the development of renal fibrosis.
• To highlight TGF-β as a central regulator of EMT and ECM production in nephropathies.

Main Methods:

• Literature review focusing on recent research findings.
• Analysis of molecular mechanisms and signaling pathways involved in renal fibrosis.
• Discussion of factors regulating TGF-β expression in renal cells.

Main Results:

• Transforming growth factor-beta (TGF-β) is identified as a major regulator inducing epithelial to mesenchymal transition (EMT) and subsequent ECM accumulation.
• TGF-β influences renal cell hypertrophy, proliferation, and apoptosis, acting as a potent profibrotic factor.
• Factors such as hyperglycemia, angiotensin II, advanced glycation end products, complement activation, and oxidative stress modulate TGF-β expression.

Conclusions:

• TGF-β plays a critical role in the pathogenesis of renal fibrosis in membranous and diabetic nephropathy.
• Targeting TGF-β signaling pathways presents a potential therapeutic strategy to mitigate renal fibrosis and prevent end-stage renal failure.